$30B Market Value Lost on World's Biggest-selling Drug Replacement Failure at Pfizer
More Stas on Pfizer the the drug industry:
- Pfizer invested as much as $1 billion in developing the new medicine to replace Lipitor.
- Analysys estimated annual sales of torcetrapib might have reached $20 billion.
- Patent expirations will cost the Pfizer $14 billion annually between 2005 and 2007.
- U.S. Retail Pharmacy Drug Sales Grew 5% to $190 billion annual rate
- IMS Health reported $379.29 billion in global drug sales through retail pharmacies in the 12-month period to August 2006.
Related topics around the web:
- Pfizer pulls the plug on Lipitor's successor MarketWatch
- Pfizer Shares Sink After Key Drug Halted Washington Post
- Pfizer Shares Drop After Cholesterol Drug Failure Bloomberg
- Pfizer Discontinues Drug Which Increases HDL Due to Higher Death Rate
- Cramer Comments on Pfizer; Also What to Expect on PFE From Here
- buyupside articles #24 - Pfizer Tumbles After Halting Torcetrapib ...
- "Pfizer suffers lethal blow to $800m 'wonder drug' trials"
- The torcetrapib disaster: Blogosphere response